Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_provenance.
- NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_assertion wasGeneratedBy ECO_0000203 NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_provenance.
- NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_assertion wasDerivedFrom befree-2016 NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_provenance.
- NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_assertion SIO_000772 17878251 NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_provenance.
- NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_assertion evidence source_evidence_literature NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_provenance.
- NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_assertion description "[The objective of the investigation was to study the efficacy of a MEK1/2 inhibitor in thyroid cancer preclinical models with defined BRAF mutation status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630723.RAguE3IqbxjwVCCj-ciRrSNS9n47B8QlbDPkvvN6LqbNQ130_provenance.